The prognosis of pemphigus patients will be significantly improved in the future.
Ikeda
S
S
Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan. ikeda@med.juntendo.ac.jp
Komiyama
E
E
Ogawa
H
H
D001379:Azathioprine / Q000627:therapeutic use; D001781:Blood Component Removal; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010392:Pemphigus / Q000503:physiopathology / Q000628:therapy*; D011239:Prednisolone / Q000627:therapeutic use*; D011379:Prognosis; D012074:Remission Induction; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011239:Prednisolone; D001379:Azathioprine